Uncategorized
Aldeyra Therapeutics to Present at the Oppenheimer & Co. 30th Annual Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that David McMullin, Chief Commercial Officer of Aldeyra, will present at Oppenheimer & Co.’s 30th Annual Healthcare Conference in New York City. The presentation is scheduled to begin at 10:55 a.m. (ET) Tuesday, March 17, 2020. A live